| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,287 |
11,000 |
$2.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,748 |
7,528 |
$1.05M |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,068 |
845 |
$262K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
332 |
273 |
$246K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,782 |
2,292 |
$185K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,464 |
1,821 |
$158K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,562 |
3,689 |
$141K |
| 80050 |
General health panel |
3,653 |
3,131 |
$139K |
| 80053 |
Comprehensive metabolic panel |
20,951 |
14,911 |
$135K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
750 |
587 |
$134K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25,980 |
19,334 |
$132K |
| 71046 |
Radiologic examination, chest; 2 views |
2,964 |
2,675 |
$125K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,297 |
1,152 |
$122K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,437 |
1,006 |
$104K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,804 |
1,064 |
$102K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,970 |
2,478 |
$78K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,412 |
2,644 |
$76K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,254 |
1,583 |
$72K |
| 76830 |
Ultrasound, transvaginal |
662 |
604 |
$67K |
| 36415 |
Collection of venous blood by venipuncture |
32,587 |
24,007 |
$64K |
| 71045 |
Radiologic examination, chest; single view |
4,794 |
3,851 |
$63K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,996 |
1,660 |
$57K |
| 99215 |
Prolong outpt/office vis |
1,061 |
1,015 |
$56K |
| 80061 |
Lipid panel |
4,442 |
3,864 |
$47K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
953 |
734 |
$46K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,075 |
1,735 |
$41K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
386 |
204 |
$27K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
324 |
281 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,757 |
1,599 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,007 |
2,563 |
$22K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
254 |
236 |
$20K |
| 82607 |
|
1,631 |
1,386 |
$20K |
| 84484 |
|
3,260 |
2,153 |
$20K |
| 80305 |
|
2,461 |
1,993 |
$19K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,882 |
1,456 |
$19K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
625 |
552 |
$19K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
628 |
552 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
627 |
552 |
$19K |
| 83880 |
|
953 |
789 |
$18K |
| G0378 |
Hospital observation service, per hour |
26 |
18 |
$16K |
| 99205 |
Prolong outpt/office vis |
303 |
269 |
$14K |
| 84481 |
|
1,184 |
1,011 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
50 |
30 |
$12K |
| 81025 |
|
2,036 |
1,662 |
$11K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
18,772 |
1,503 |
$11K |
| 82553 |
|
2,017 |
1,404 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,744 |
1,393 |
$10K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
139 |
76 |
$9K |
| 82550 |
|
2,679 |
1,888 |
$9K |
| 84439 |
|
1,198 |
1,012 |
$9K |
| 81001 |
|
4,655 |
3,745 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
251 |
108 |
$8K |
| 0001A |
|
239 |
221 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,167 |
1,034 |
$8K |
| 0002A |
|
210 |
184 |
$7K |
| 93000 |
|
235 |
193 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
489 |
418 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
46 |
17 |
$6K |
| 83690 |
|
1,447 |
1,130 |
$6K |
| 0240U |
|
39 |
38 |
$6K |
| 82746 |
|
476 |
394 |
$5K |
| 85730 |
|
1,703 |
1,350 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
39 |
35 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
580 |
455 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27 |
27 |
$4K |
| 85610 |
|
1,683 |
1,367 |
$4K |
| 81003 |
|
2,867 |
2,253 |
$4K |
| 84403 |
|
131 |
111 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
410 |
357 |
$3K |
| 83735 |
|
761 |
518 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
347 |
169 |
$2K |
| 83540 |
|
428 |
365 |
$2K |
| 74018 |
|
46 |
39 |
$2K |
| 84146 |
|
99 |
90 |
$2K |
| 83001 |
|
103 |
91 |
$1K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
43 |
12 |
$1K |
| 82670 |
|
59 |
50 |
$1K |
| 84100 |
|
416 |
297 |
$964.51 |
| 84436 |
|
243 |
195 |
$837.28 |
| 86780 |
|
76 |
62 |
$797.65 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$795.92 |
| 87040 |
|
120 |
59 |
$621.56 |
| 86677 |
|
85 |
52 |
$620.80 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
27 |
25 |
$602.00 |
| 80150 |
|
52 |
47 |
$545.52 |
| J2704 |
Injection, propofol, 10 mg |
2,082 |
1,666 |
$534.28 |
| 86850 |
|
140 |
117 |
$521.70 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
27 |
27 |
$506.37 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$444.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
490 |
438 |
$438.69 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
705 |
554 |
$337.27 |
| 86901 |
|
141 |
117 |
$312.84 |
| 86900 |
|
141 |
117 |
$312.84 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,416 |
1,043 |
$261.86 |
| 82672 |
|
15 |
12 |
$238.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,187 |
1,010 |
$230.28 |
| 86803 |
|
20 |
18 |
$228.32 |
| 82150 |
|
53 |
48 |
$222.84 |
| 86140 |
|
66 |
51 |
$218.82 |
| 86703 |
|
12 |
12 |
$158.07 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
570 |
492 |
$141.23 |
| 86039 |
|
23 |
12 |
$125.48 |
| 87077 |
|
15 |
12 |
$121.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,197 |
933 |
$111.33 |
| J3490 |
Unclassified drugs |
308 |
249 |
$109.72 |
| 87070 |
|
12 |
12 |
$103.44 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
12 |
$66.88 |
| 86592 |
|
12 |
12 |
$49.58 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
80 |
62 |
$26.68 |
| 82962 |
|
15 |
13 |
$12.76 |
| J1644 |
Injection, heparin sodium, per 1000 units |
22 |
13 |
$10.33 |
| 91300 |
|
666 |
573 |
$5.02 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
47 |
37 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
104 |
83 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
80 |
66 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
281 |
199 |
$0.00 |
| 81002 |
|
18 |
13 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
14 |
12 |
$0.00 |